Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China
Cue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China. The Boston-based biotech has focused on developing T ...
Shao-Lee Lin, new Cue Biopharma CEO May 1, 2026 11:27 AM EDT PeopleDealsChina Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China Lei Lei Wu News Reporter Cue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that